545 related articles for article (PubMed ID: 9417150)
41. Endocrinological abnormalities in angiotensinogen-gene knockout mice: studies of hormonal responses to dietary salt loading.
Umemura S; Kihara M; Sumida Y; Yabana M; Ishigami T; Tamura K; Nyui N; Hibi K; Murakami K; Fukamizu A; Ishii M
J Hypertens; 1998 Mar; 16(3):285-9. PubMed ID: 9557921
[TBL] [Abstract][Full Text] [Related]
42. Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.
Gant CM; Laverman GD; Vogt L; Slagman MCJ; Heerspink HJL; Waanders F; Hemmelder MH; Navis G;
BMC Nephrol; 2017 Dec; 18(1):370. PubMed ID: 29262813
[TBL] [Abstract][Full Text] [Related]
43. Activated renin-angiotensin-aldosterone system and its effects on cardiovascular system during 20-days horizontal bed rest.
Haruna Y; Suzuki Y; Yanagibori R; Kawakubo K; Gunji A
J Gravit Physiol; 1995; 2(1):P27-8. PubMed ID: 11538920
[TBL] [Abstract][Full Text] [Related]
44. Role of the renin-angiotensin system during alterations of sodium intake in conscious mice.
Cholewa BC; Mattson DL
Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R987-93. PubMed ID: 11507017
[TBL] [Abstract][Full Text] [Related]
45. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the renin-angiotensin-aldosterone system in fibromyalgia.
Maliszewski AM; Goldenberg DL; Hurwitz S; Adler GK
J Rheumatol; 2002 Jul; 29(7):1482-7. PubMed ID: 12136909
[TBL] [Abstract][Full Text] [Related]
47. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
48. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
49. The renin-aldosterone axis in patients with diabetes insipidus.
Antaraki A; Rangou D; Chlouverakis C
Clin Endocrinol (Oxf); 1994 Apr; 40(4):505-10. PubMed ID: 8187317
[TBL] [Abstract][Full Text] [Related]
50. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
51. Independence of salt intake induced by calcium deprivation from the renin-angiotensin-aldosterone system.
Tordoff MG; Pilchak DM; Hughes RL
Am J Physiol; 1993 Mar; 264(3 Pt 2):R492-9. PubMed ID: 8457002
[TBL] [Abstract][Full Text] [Related]
52. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Brown NJ; Agirbasli MA; Williams GH; Litchfield WR; Vaughan DE
Hypertension; 1998 Dec; 32(6):965-71. PubMed ID: 9856958
[TBL] [Abstract][Full Text] [Related]
53. Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.
MacFadyen RJ; Lees KR; Reid JL
Br J Clin Pharmacol; 1994 Oct; 38(4):329-34. PubMed ID: 7833222
[TBL] [Abstract][Full Text] [Related]
54. Chronic activation of plasma renin is log-linearly related to dietary sodium and eliminates natriuresis in response to a pulse change in total body sodium.
Kjolby M; Bie P
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R17-25. PubMed ID: 17989136
[TBL] [Abstract][Full Text] [Related]
55. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites.
He FJ; Markandu ND; MacGregor GA
Hypertension; 2001 Sep; 38(3):321-5. PubMed ID: 11566898
[TBL] [Abstract][Full Text] [Related]
56. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
Laragh JH
N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
[TBL] [Abstract][Full Text] [Related]
57. Effects of angiotensin-converting enzyme inhibition on renal dysfunction induced by moderate potassium depletion in healthy women.
Agnoli GC; Borgatti R; Cacciari M; Ikonomu E; Lenzi P; Marinelli M
Clin Physiol; 1994 Mar; 14(2):205-22. PubMed ID: 8205752
[TBL] [Abstract][Full Text] [Related]
58. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
59. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism.
Clinkingbeard C; Sessions C; Shenker Y
J Clin Endocrinol Metab; 1990 Mar; 70(3):582-9. PubMed ID: 2137830
[TBL] [Abstract][Full Text] [Related]
60. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC
J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
